feedzop-word-mark-logo
searchLogin
Feedzop
homeFor YouIndiaIndia
You
bookmarksYour BookmarkshashtagYour Topics
Trending
Terms of UsePrivacy PolicyAboutJobsPartner With Us

© 2026 Advergame Technologies Pvt. Ltd. ("ATPL"). Gamezop ® & Quizzop ® are registered trademarks of ATPL.

Gamezop is a plug-and-play gaming platform that any app or website can integrate to bring casual gaming for its users. Gamezop also operates Quizzop, a quizzing platform, that digital products can add as a trivia section.

Over 5,000 products from more than 70 countries have integrated Gamezop and Quizzop. These include Amazon, Samsung Internet, Snap, Tata Play, AccuWeather, Paytm, Gulf News, and Branch.

Games and trivia increase user engagement significantly within all kinds of apps and websites, besides opening a new stream of advertising revenue. Gamezop and Quizzop take 30 minutes to integrate and can be used for free: both by the products integrating them and end users

Increase ad revenue and engagement on your app / website with games, quizzes, astrology, and cricket content. Visit: business.gamezop.com

Property Code: 5571

Home / Science / Home Alzheimer's Test: Finger Prick Breakthrough?

Home Alzheimer's Test: Finger Prick Breakthrough?

19 Jan

•

Summary

  • A new finger-prick blood test aims to detect Alzheimer's risk.
  • Trial involves 1,000 volunteers, with results expected in 2028.
  • This test could allow for home-based screening without refrigeration.
Home Alzheimer's Test: Finger Prick Breakthrough?

A novel finger-prick blood test is currently undergoing trials, offering a potential breakthrough in early Alzheimer's detection. Scientists are analyzing results from 1,000 volunteers to determine the test's efficacy in identifying abnormal amyloid protein, a key indicator of Alzheimer's risk. Dr. Emer MacSweeney highlights its potential for a ubiquitous, accurate, and less complicated diagnostic tool.

The ongoing study seeks to understand if blood tests can improve diagnosis and treatment in real-world scenarios, with a US regulator having already approved a needle-and-syringe blood test for Alzheimer's diagnosis last year. A significant advantage of this finger-prick method is its suitability for home use, as samples do not require refrigeration and can be mailed to a lab.

The trial, which includes participants with varying cognitive statuses, aims to complete by 2028, with at least 25% of volunteers from under-represented groups. Hopes are high that such blood tests could eventually serve as a crucial screening tool for dementia in older adults, making early detection more accessible.

trending

Train collision in Adamuz, Spain

trending

UAE President visits India

trending

Champions League crunch time

trending

Stock market closed: BioNTech upgraded

trending

Barcelona fitness boost for UCL

trending

RCB wins WPL table

trending

PwC proposes Hong Kong tax relief

trending

RCB crushes Gujarat Giants

Disclaimer: This story has been auto-aggregated and auto-summarised by a computer program. This story has not been edited or created by the Feedzop team.
Dr. Emer MacSweeney is involved with a finger-prick blood test trial aimed at detecting Alzheimer's risk.
The trial is expected to complete in 2028, with results analyzed thereafter.
Yes, a key advantage of the finger-prick test is its potential for home use, with samples mailed to a lab.

Read more news on

Scienceside-arrow

You may also like

Blood Sugar Spikes Linked to Alzheimer's Risk

16 Jan • 23 reads

article image

Vaccines May Slash Dementia Risk, Study Shows

7 Jan • 111 reads

article image

Alzheimer's Blood Tests: Track Changes Over Time

18 Dec, 2025 • 137 reads

article image

Stomach Bug Protein Fights Alzheimer's Plaque

7 Dec, 2025 • 231 reads

article image

Tiny Genetic Flaw Causes 'Baby Alzheimer's'

6 Dec, 2025 • 270 reads

article image